Miromatrix Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	0.96	0.95	0.03	0.05	0.25
Revenue Growth (YoY)	2978.99%	2783.54%	-28.94%	-81.39%	-
Cost of Revenue	0.5	0.5	0.5	0.5	0.25
Gross Profit	0.46	0.45	-0.47	-0.45	0
Selling, General & Admin	8.99	8.72	4.64	2.11	2.44
Research & Development	16.25	18.3	10.76	7.28	6.27
Other Operating Expenses	3.82	3.79	1.1	0.42	0.29
Operating Expenses	29.06	30.82	16.5	9.81	8.99
Operating Income	-28.6	-30.36	-16.96	-10.26	-8.99
Interest Expense / Income	0.05	0.05	0.61	0.66	0.05
Other Expense / Income	-1.24	-0.45	-2.91	-0.61	-4.99
Pretax Income	-27.41	-29.96	-14.67	-10.31	-4.05
Net Income	-27.41	-29.96	-14.67	-10.31	-4.05
Shares Outstanding (Basic)	27	21	11	2	2
Shares Outstanding (Diluted)	27	21	11	2	2
Shares Change	30.72%	80.48%	430.44%	5.96%	-
EPS (Basic)	-1.15	-1.45	-1.28	-4.76	-1.98
EPS (Diluted)	-1.15	-1.45	-1.28	-4.76	-1.98
Free Cash Flow	-24.55	-27.75	-18.19	-8.16	-8.43
Free Cash Flow Per Share	-0.90	-1.34	-1.58	-3.77	-4.12
Gross Margin	47.81%	47.56%	-1412.13%	-974.58%	-
Operating Margin	-2985.57%	-3184.62%	-51306.44%	-22047.17%	-3596.67%
Profit Margin	-2861.11%	-3142.21%	-44368.10%	-22156.82%	-1618.72%
Free Cash Flow Margin	-2562.59%	-2909.97%	-55018.28%	-17539.04%	-3370.47%
EBITDA	-26.21	-28.8	-13.89	-9.48	-3.65
EBITDA Margin	-2735.38%	-3020.95%	-42003.77%	-20379.65%	-1461.71%
Depreciation & Amortization	1.16	1.11	0.17	0.17	0.34
EBIT	-27.36	-29.91	-14.06	-9.65	-4
EBIT Margin	-2856.27%	-3137.20%	-42511.56%	-20745.79%	-1599.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).